Drug and medical device firm Abbott Laboratories says it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies. Get the full story »
Inside these posts: Flu-vaccine
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Flu vaccines on the way earlier than usual
Two flu vaccine makers said Friday that they had started shipping supplies for the U.S. market, one of the earliest starts to distributing seasonal influenza vaccine.
And U.S. officials said they were changing the labeling on a vaccine made by Australia’s CSL Ltd. because it appears to have caused a higher than usual rate of seizures in children. Get the full story »
Abbott to sell Solvay’s flu-vaccine operation
From the Wall Street Journal | Abbott Labs has put the flu-vaccine business of Solvay SA up for sale. British pharmaceuticals giants GlaxoSmithKline and AstraZeneca are considered leading candidates to pick up the operation, expected to sell for around $617 million.
Abbott bought the drug business of Belgium’s Solvay in September.
